Literature DB >> 26110238

Increased excitability of medium-sized dorsal root ganglion neurons by prolonged interleukin-1β exposure is K(+) channel dependent and reversible.

Patrick L Stemkowski1, Myung-Chul Noh2, Yishen Chen2, Peter A Smith2.   

Abstract

KEY POINTS: Neuropathic pain resulting from peripheral nerve injury is initiated and maintained by persistent ectopic activity in primary afferent neurons. Sciatic nerve injury increases the excitability of medium-sized dorsal root ganglion (DRG) neurons. Levels of the inflammatory cytokine interleukin 1β (IL-1β) increase and peak after 7 days. Five to six days of exposure of medium sized DRG neurons to 100 pm IL-1β promotes persistent increases in excitability which abate within 3-4 days of cytokine removal. This is associated with a profound attenuation of K(+) channel currents but only modest increases in function of cyclic nucleotide-sensitive hyperpolarization-activated channels (HCNs) and of voltage-gated Na(+) and Ca(2+) channel currents. It is unlikely, therefore, that direct interaction of IL-1β with DRG neurons is capable of initiating an enduring phenotypic shift in their electrophysiological properties that follows sciatic nerve injury. The findings also underline the importance of K(+) channel modulation in the actions of inflammatory mediators on peripheral neurons. ABSTRACT: Chronic constriction injury of rat sciatic nerve promotes signs of neuropathic pain. This is associated with an increase in the level of interleukin 1β (IL-1β) in primary afferents that peaks at 7 days. This initial cytokine exposure has been proposed to trigger an enduring alteration in neuronal phenotype that underlies chronic hyper-excitability in sensory nerves, which initiates and maintains chronic neuropathic pain. We have shown previously that 5-6 days of exposure of rat dorsal root ganglia (DRGs) to 100 pm IL-1β increases the excitability of medium-sized neurons. We have now found using whole-cell recording that this increased excitability reverts to control levels within 3-4 days of cytokine removal. The effects of IL-1β were dominated by changes in K(+) currents. Thus, the amplitudes of A-current, delayed rectifier and Ca(2+) -sensitive K(+) currents were reduced by ∼68%, ∼64% and ∼36%, respectively. Effects of IL-1β on other cation currents were modest by comparison. There was thus a slight decrease in availability of high voltage-activated Ca(2+) channel current, a small increase in rates of activation of hyperpolarization-activated cyclic nucleotide-gated channel current (IH ), and a shift in the voltage dependence of activation of tetrodotoxin-sensitive sodium current (TTX-S INa ) to more negative potentials. It is unlikely, therefore, that direct interaction of IL-1β with DRG neurons initiates an enduring phenotypic shift in their electrophysiological properties following sciatic nerve injury. Persistent increases in primary afferent excitability following nerve injury may instead depend on altered K(+) channel function and on the continued presence of slightly elevated levels IL-1β and other cytokines.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26110238      PMCID: PMC4560594          DOI: 10.1113/JP270905

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  76 in total

1.  Differential inhibition of transient outward currents of Kv1.4 and Kv4.3 by endothelin.

Authors:  Kunie Hagiwara; Kazuo Nunoki; Kuniaki Ishii; Takaaki Abe; Teruyuki Yanagisawa
Journal:  Biochem Biophys Res Commun       Date:  2003-10-17       Impact factor: 3.575

2.  The presence of Ca2+ channel beta subunit is required for mitogen-activated protein kinase (MAPK)-dependent modulation of alpha1B Ca2+ channels in COS-7 cells.

Authors:  Elizabeth M Fitzgerald
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

3.  Nociceptin inhibits T-type Ca2+ channel current in rat sensory neurons by a G-protein-independent mechanism.

Authors:  F A Abdulla; P A Smith
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

4.  Molecular mechanism of cAMP modulation of HCN pacemaker channels.

Authors:  B J Wainger; M DeGennaro; B Santoro; S A Siegelbaum; G R Tibbs
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

5.  Expression of interleukin-1 beta in rat dorsal root ganglia.

Authors:  J C Copray; I Mantingh; N Brouwer; K Biber; B M Küst; R S Liem; I Huitinga; F J Tilders; A M Van Dam; H W Boddeke
Journal:  J Neuroimmunol       Date:  2001-08-30       Impact factor: 3.478

6.  Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury.

Authors:  Eran Gabay; Gilly Wolf; Yehuda Shavit; Raz Yirmiya; Michael Tal
Journal:  Eur J Pain       Date:  2010-08-30       Impact factor: 3.931

7.  Hyperpolarization-activated cyclic nucleotide-gated channel mRNA and protein expression in large versus small diameter dorsal root ganglion neurons: correlation with hyperpolarization-activated current gating.

Authors:  E V Kouranova; B W Strassle; R H Ring; M R Bowlby; D V Vasilyev
Journal:  Neuroscience       Date:  2008-03-22       Impact factor: 3.590

Review 8.  TNF-alpha and neuropathic pain--a review.

Authors:  Lawrence Leung; Catherine M Cahill
Journal:  J Neuroinflammation       Date:  2010-04-16       Impact factor: 8.322

9.  Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons.

Authors:  K C Kajander; G J Bennett
Journal:  J Neurophysiol       Date:  1992-09       Impact factor: 2.714

10.  Axotomy- and autotomy-induced changes in the excitability of rat dorsal root ganglion neurons.

Authors:  F A Abdulla; P A Smith
Journal:  J Neurophysiol       Date:  2001-02       Impact factor: 2.714

View more
  18 in total

Review 1.  Neuromodulation by the immune system: a focus on cytokines.

Authors:  Andrea Francesca Salvador; Kalil Alves de Lima; Jonathan Kipnis
Journal:  Nat Rev Immunol       Date:  2021-03-01       Impact factor: 53.106

Review 2.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

Review 3.  Targeting cytokines for treatment of neuropathic pain.

Authors:  Alice L Hung; Michael Lim; Tina L Doshi
Journal:  Scand J Pain       Date:  2017-08-24

Review 4.  Origins of Phantom Limb Pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

5.  Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10.

Authors:  Mariaconcetta Durante; Silvia Squillace; Filomena Lauro; Luigino Antonio Giancotti; Elisabetta Coppi; Federica Cherchi; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Grant Kolar; Carrie Wahlman; Adeleye Opejin; Cuiying Xiao; Marc L Reitman; Dilip K Tosh; Daniel Hawiger; Kenneth A Jacobson; Daniela Salvemini
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

6.  Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release.

Authors:  Hana Starobova; Mercedes Monteleone; Christelle Adolphe; Lena Batoon; Cheyenne J Sandrock; Bryan Tay; Jennifer R Deuis; Alexandra V Smith; Alexander Mueller; Evelyn Israel Nadar; Grace Pamo Lawrence; Amanda Mayor; Elissa Tolson; Jean-Pierre Levesque; Allison R Pettit; Brandon J Wainwright; Kate Schroder; Irina Vetter
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

7.  NLRP3 Inflammasome Blockade Reduces Cocaine-Induced Microglial Activation and Neuroinflammation.

Authors:  Ernest T Chivero; Annadurai Thangaraj; Ashutosh Tripathi; Palsamy Periyasamy; Ming-Lei Guo; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

8.  Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway.

Authors:  Patrick L Stemkowski; Agustin Garcia-Caballero; Vinicius M Gadotti; Said M'Dahoma; Lina Chen; Ivana A Souza; Gerald W Zamponi
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

9.  Glial interleukin-1β upregulates neuronal sodium channel 1.7 in trigeminal ganglion contributing to temporomandibular joint inflammatory hypernociception in rats.

Authors:  Peng Zhang; Rui-Yun Bi; Ye-Hua Gan
Journal:  J Neuroinflammation       Date:  2018-04-20       Impact factor: 8.322

Review 10.  Microglia and CNS Interleukin-1: Beyond Immunological Concepts.

Authors:  Xiaoyu Liu; Ning Quan
Journal:  Front Neurol       Date:  2018-01-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.